dc.contributor.author |
Warman, Guy |
en |
dc.contributor.author |
Pawley, Matthew |
en |
dc.contributor.author |
Bolton, C |
en |
dc.contributor.author |
Cheeseman, James |
en |
dc.contributor.author |
Fernando, Antonio |
en |
dc.contributor.author |
Arendt, J |
en |
dc.contributor.author |
Wirz-Justice, A |
en |
dc.coverage.spatial |
United States |
en |
dc.date.accessioned |
2012-03-07T22:30:00Z |
en |
dc.date.issued |
2011 |
en |
dc.identifier.citation |
PLoS One 6(7):e22073 2011 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/13357 |
en |
dc.description.abstract |
Study Objectives: To determine the prevalence of self-reported circadian-related sleep disorders, sleep medication and melatonin use in the New Zealand blind population. Design: A telephone survey incorporating 62 questions on sleep habits and medication together with validated questionnaires on sleep quality, chronotype and seasonality. Participants: Participants were grouped into: (i) 157 with reduced conscious perception of light (RLP); (ii) 156 visually impaired with no reduction in light perception (LP) matched for age, sex and socioeconomic status, and (iii) 156 matched fully-sighted controls (FS). Sleep Habits and Disturbances: The incidence of sleep disorders, daytime somnolence, insomnia and sleep timing problems was significantly higher in RLP and LP compared to the FS controls (p,0.001). The RLP group had the highest incidence (55%) of sleep timing problems, and 26% showed drifting sleep patterns (vs. 4% FS). Odds ratios for unconventional sleep timing were 2.41 (RLP) and 1.63 (LP) compared to FS controls. For drifting sleep patterns, they were 7.3 (RLP) and 6.0 (LP). Medication Use: Zopiclone was the most frequently prescribed sleep medication. Melatonin was used by only 4% in the RLP group and 2% in the LP group. Conclusions: Extrapolations from the current study suggest that 3,000 blind and visually impaired New Zealanders may suffer from circadian-related sleep problems, and that of these, fewer than 15% have been prescribed melatonin. This may represent a therapeutic gap in the treatment of circadian-related sleep disorders in New Zealand, findings that may generalize to other countries. |
en |
dc.language |
eng |
en |
dc.publisher |
The Authors |
en |
dc.relation.ispartofseries |
PLOS ONE |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from: http://www.sherpa.ac.uk/romeo/issn/1932-6203/ |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.subject |
Adolescent |
en |
dc.subject |
Adult |
en |
dc.subject |
Age Distribution |
en |
dc.subject |
Aged |
en |
dc.subject |
Aged, 80 and over |
en |
dc.subject |
Child |
en |
dc.subject |
Child, Preschool |
en |
dc.subject |
Female |
en |
dc.subject |
General Practitioners |
en |
dc.subject |
Health Surveys |
en |
dc.subject |
Humans |
en |
dc.subject |
Infant |
en |
dc.subject |
Infant, Newborn |
en |
dc.subject |
Male |
en |
dc.subject |
Middle Aged |
en |
dc.subject |
New Zealand |
en |
dc.subject |
Prevalence |
en |
dc.subject |
Self Report |
en |
dc.subject |
Sleep Disorders, Circadian Rhythm |
en |
dc.subject |
Visually Impaired Persons |
en |
dc.subject |
Young Adult |
en |
dc.title |
Circadian-related sleep disorders and sleep medication use in the New Zealand blind population: an observational prevalence survey. |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.1371/journal.pone.0022073 |
en |
pubs.issue |
7 |
en |
pubs.begin-page |
e22073 |
en |
pubs.volume |
6 |
en |
dc.rights.holder |
Copyright: PLoS; The Authors |
en |
dc.identifier.pmid |
21789214 |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Article |
en |
pubs.elements-id |
217274 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
School of Medicine |
en |
pubs.org-id |
Anaesthesiology |
en |
dc.identifier.eissn |
1932-6203 |
en |
dc.identifier.pii |
PONE-D-11-07513 |
en |
pubs.record-created-at-source-date |
2012-03-08 |
en |
pubs.dimensions-id |
21789214 |
en |